Plyzer Technologies signs pharma company Heel as a new SaaS client for its business intelligence platform, Plyzer Intelligence

Plyzer Technologies continues to build sales momentum and expects more to come over the coming weeks and months.

Plyzer Technologies Inc. ("the Company") (PLYZ: OTCQB) is pleased to announce that it has signed the pharmaceutical company Heel, which specializes in developing and manufacturing medicines made from natural ingredients, as a new SaaS customer for its business intelligence and analytics software, Plyzer Intelligence.

Heel is a German company that employs more than 1,350 people worldwide. The company's turnover in 2018 was over €200 million. More information about Heel can be found by visiting https://www.heel.es

“Heel is a pioneer in the field of natural medicine, a flourishing industry in the e-commerce space. We look forward to helping Heel generate more sales through the intelligent use of data", said Luis Pallares, founder and CEO of Plyzer Technologies Corporation.

For more information about:
Plyzer Technologies: www.plyzertechnologies.com
Plyzer Intelligence: www.plyzerintelligence.com
Plyzer App: www.plyzer.com

Sales enquiries can be directed to:

In Europe:
Susana León - [email protected]

In North America:
Alexi Chatzilias - [email protected]